Use of insulin pump therapy in patients with type 2 diabetes after failure of multiple daily injections

Endocrine Practice

Volumn 19, Issue 1, 2013, Pages 9-13

  Leinung, Matthew C ^a   Thompson, Shannon ^a   Luo, Mingfei ^a   Leykina, Lina ^a   Nardacci, Elizabeth ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLARGINE; GLYCOSYLATED HEMOGLOBIN; INSULIN DETEMIR; LONG ACTING INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CONTINUOUS INFUSION; DIABETIC PATIENT; DISEASE SEVERITY; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN PUMP; INSULIN RESISTANCE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; INSULIN INFUSION; MIDDLE AGED; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; INSULIN, LONG-ACTING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84881539226     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP12104.OR     Document Type: Article

References (16)

1. Leahy JL, Pratley RE. What is type 2 diabetes mellitus? Crucial role of maladaptive changes in beta cell and adipocyte biology. Translational Endocrinol and Metab. 2011;2:9-42.
2. Holman RR, Farmer AJ, Davies MJ, et al. Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med. 2009;361:1736-1747.
3. Bode BW. Insulin pump use in type 2 diabetes. Diab Tech and Ther. 2010;12(Supp 1):S17-S21.
4. Lynch P, Riedel AA, Samant N, et al. Improved A1C by switching to continuous subcutaneous insulin infusion from injection insulin therapy in type 2 diabetes: a retrospective claims analysis. Prim Care Diabetes. 2010;4:209-214.
5. Berthe E, Lireux B, Coffin C, et al. Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure. Horm Metab Res. 2007;39:224-229. (Pubitemid 46580623)
6. Raskin P, Bode BW, Marks JB, et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care. 2003;26:2598-2603. (Pubitemid 37052106)
7. Herman WH, Ilag LL, Johnson SL, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care. 2005;28:1568-1573. (Pubitemid 40923066)
8. Wainstein J, Metzger M, Boaz M, et al. Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients. Diabet Med. 2005;22:1037-1046. (Pubitemid 41026001)
9. Johnson SL, McEwen LN, Newton CA, et al. The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetes. J Diabetes Complications. 2011;25:211-215.
10. Jennings AM, Lewis KS, Murdoch S, Talbot JF, Bradley C, Ward JD. Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas. Diabetes Care. 1991;14:738-744.
11. Lane WS, Weinrib SL, Rappaport JM, Przestraelski T. A prospective trial of U-500 insulin delivered by omnipod in patients with type 2 diabetes mellitus and severe insulin resistance. Endocr Pract. 2010;16:778-784.
12. Kapitza C, Fein S, Heinemann L, Schleusener D, Levesque S, Strange P. Basal-prandial insulin delivery in type 2 diabetes mellitus via the V-Go: a novel continuous subcutaneous infusion device. J Diabetes Sci Technol. 2008;2:40-46.
13. Labrousse-Lhermine F, Cazals L, Ruidavets JB, Hanaire H. Long-term treatment combining continuous subcutaneous insulin infusion with oral hypoglycaemic agents is effective in type 2 diabetes. Diabetes Metab. 2007;33:253-260. (Pubitemid 47418702)
14. Parkner T, Laursen T, Vestergaard ET, et al. Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in type 2 diabetes. Diabet Med. 2008;25:585-591. (Pubitemid 351590882)
15. Wolff-McDonagh P, Kaufmann J, Foreman S, Wisotsky S, Wisotsky J, Wexler C. Using Insulin Pump Therapy in Poorly Controlled Type 2 Diabetes. The Diabetes Educ. 2010;36:657-665.
16. Gentry CH, Cross LB, Gross BN, McFarland MS, Bestermann WH. Retrospective Analysis and Patient Satisfaction Assessment of Insulin Pump Therapy in Patients with Type 2 Diabetes. South Med J. 2011;104:24-28